{
  "id": "06892531e9d96f95",
  "title": "BioNexus Gene Lab Corp. Completes Strategic Investment in Fidelion Diagnostics; Secures 15% Equity Stake in Global AI-Oncology Platform and Exclusive Southeast Asian Rights for VitaGuard\u2122",
  "description": "KUALA LUMPUR, Malaysia, Dec. 03, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ: BGLC) (\"BGLC\" or the \"Company\"), a biotechnology company advancing precision diagnostics and gene-based technologies, today announced the formal completion of its strat\u2026",
  "content": "KUALA LUMPUR, Malaysia, Dec. 03, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ: BGLC) (\"BGLC\" or the \"Company\"), a biotechnology company advancing precision diagnostics and gene-based tech\u2026 [+7245 chars]",
  "source": "GlobeNewswire",
  "source_url": "https://www.globenewswire.com/news-release/2025/12/03/3198909/0/en/BioNexus-Gene-Lab-Corp-Completes-Strategic-Investment-in-Fidelion-Diagnostics-Secures-15-Equity-Stake-in-Global-AI-Oncology-Platform-and-Exclusive-Southeast-Asian-Rights-for-VitaGu.html",
  "published_at": "2025-12-03T13:45:00Z",
  "fetched_at": "2025-12-06T18:33:06.472112+00:00",
  "category": "ai_machine_intelligence",
  "subcategory": null,
  "keywords": [
    "ai",
    "search:IPO market activity"
  ],
  "location": null,
  "raw_data": {
    "source": {
      "id": null,
      "name": "GlobeNewswire"
    },
    "author": "BioNexus Gene Lab Corp.",
    "title": "BioNexus Gene Lab Corp. Completes Strategic Investment in Fidelion Diagnostics; Secures 15% Equity Stake in Global AI-Oncology Platform and Exclusive Southeast Asian Rights for VitaGuard\u2122",
    "description": "KUALA LUMPUR, Malaysia, Dec. 03, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ: BGLC) (\"BGLC\" or the \"Company\"), a biotechnology company advancing precision diagnostics and gene-based technologies, today announced the formal completion of its strat\u2026",
    "url": "https://www.globenewswire.com/news-release/2025/12/03/3198909/0/en/BioNexus-Gene-Lab-Corp-Completes-Strategic-Investment-in-Fidelion-Diagnostics-Secures-15-Equity-Stake-in-Global-AI-Oncology-Platform-and-Exclusive-Southeast-Asian-Rights-for-VitaGu.html",
    "urlToImage": null,
    "publishedAt": "2025-12-03T13:45:00Z",
    "content": "KUALA LUMPUR, Malaysia, Dec. 03, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ: BGLC) (\"BGLC\" or the \"Company\"), a biotechnology company advancing precision diagnostics and gene-based tech\u2026 [+7245 chars]"
  }
}